Cosentyx 00078-1168
Generic: Secukinumab
Product NDC
00078-1168- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 6, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA761349
Need to source Cosentyx? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Secukinumab | 25 mg/mL |
Drug Class
Interleukin-17A Antagonist [EPC]Interleukin-17A Antagonist [EPC]Interleukin-17A Antagonists [MoA]
Packaging Options(1)
5 mL in 1 VIAL, GLASS (0078-1168-61)